FDA MedWatch - ShoulderFlex Massager by King International: Safety Communication - Risk of Strangulation

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA MedWatch - ShoulderFlex Massager by King International: Safety Communication - Risk of Strangulation
MedWatch logoMedWatch - The FDA Safety Information and Adverse Event Reporting Program

ShoulderFlex Massager by King International: Safety Communication - Risk of Strangulation

AUDIENCE: Physical Medicine, Orthopedics, Consumer

ISSUE: FDA notified health professionals and consumers of serious health risks posed by the ShoulderFlex Massager. FDA is aware of reports to the Consumer Product Safety Commission of one death and one near-strangulation associated with the ShoulderFlex Massager. These incidents occurred when a necklace and clothing became caught in a piece of the device that rotates during use. Two other reports involved clothing and hair became caught in the device. 

BACKGROUND: The ShoulderFlex Massager, distributed by King International, is a personal massage device designed for home use to provide deep tissue massage to the neck, shoulder and back while the user lies on a flat surface. King International has distributed 11,934 devices since Oct. 18, 2003. The devices were sold at various stores and online retailers in the United States. 

RECOMMENDATION: Do not use or recommend use of the ShoulderFlex Massager. Dispose of the device components separately so that the massager cannot be reassembled and used. The FDA is evaluating King International’s plan for recall of the ShoulderFlex Massager, which may lead to additional action or communication by the FDA or King International.

Prompt reporting of adverse events can help the FDA identify and better understand the risks associated with this product. Healthcare professionals and patients are encouraged to report adverse events or side effects to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Read the MedWatch safety alert, including a link to the FDA safety communication, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm269765.htm

Tell us how we are doing:

http://survey.foreseeresults.com/survey/display?cid=d509U9xg0gZVxkMRcoMsQg==&sid=link&cpp[date]=08_26_2011_1200&cpp[type]=S


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux